MTOR and familial hyperaldosteronism: Overall, metformin improved memory function and astrocyte reactivity in LDLr−/− mice independently of cholesterol reduction and without demonstrable involvement of the AMPK/mTOR pathway, suggesting its potential as a therapeutic strategy for FH-associated brain dysfunction.